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End-Organ Function and Exercise
Performance in Patients With Fontan
Circulation: What Characterizes the High
Performers?
Scott J. Weinreb, MD; Kathryn M. Dodds, RN, MSN, CRNP; Danielle S. Burstein , MD;
Jing Huang, PhD; Elizabeth B. Rand, MD; Edna Mancilla, MD; Jennifer R. Heimall, MD;
Michael G. McBride, PhD; Stephen M. Paridon, MD; David J. Goldberg, MD; Jack Rychik

, MD

BACKGROUND: The physiologic hallmarks of the Fontan circulation—chronically elevated central venous pressures and low cardiac output—have significant effects not only on cardiovascular status but also impact other organ systems. Exercise capacity
is limited in many and declines with age, accelerating in adolescence, but with wide variability. We explore the relationship
between exercise performance and end-organ function in outpatient subjects with a Fontan circulation.
METHODS AND RESULTS: This is a cross-sectional analysis of subject end-organ characterization from our outpatient Fontan
circulation clinic with peak oxygen consumption (peak Vo2) at cardiopulmonary exercise testing as the primary outcome. We
perform linear regression to assess associations between clinical characteristics and peak Vo2 as well as the magnitude of
the association of clinical characteristics with peak Vo2. Of 265 subjects age 12.8 (9.5–16.4) years, there is a negative correlation between age and peak Vo2 (−0.49, P<0.001). Of those undergoing ramp cycle exercise testing, 34% perform above 80%
predicted peak Vo2. Variables positively associated with peak Vo2 and their effect size include vitamin D sufficiency (+3.00,
P=0.020) and absolute lymphocyte count (+0.23, P=0.005). Status as overweight/obese (−3.91, P=0.003) and hemoglobin
(−0.77, P=0.003) are negatively associated. Neither ventricular morphology, timing of Fontan palliation, nor Fontan circulation
type affect peak Vo2.
CONCLUSIONS: Higher peak Vo2 in those with a Fontan circulation is associated with younger age, vitamin D sufficiency, absence of overweight/obese, lower hemoglobin, and a healthier hepatic profile. Whether exercise training or other initiatives can
modify organ characteristics in those with a Fontan circulation is worthy of exploration.
Key Words: congenital heart disease ■ exercise testing ■ Fontan procedure ■ single ventricle

S

trategies of care for those born with single ventricle congenital heart disease culminates in the
channeling of systemic venous return directly to
the pulmonary circulation without ventricular thrust, a
state known as the Fontan circulation.1 Implementation
of this surgical approach currently allows for long-term
outcomes with survival ranging from 75% to 80% at
up to 25 years of age.2,3 The physiologic hallmarks of
the Fontan circulation—chronically elevated central

venous pressure and low cardiac output—have significant effects not only on cardiovascular status but
also potentially impact other organ systems. Hepatic,
endocrine, renal, and lymphatic systems can all be
negatively affected, with variable degrees of dysfunction reported.4 It is well recognized that overall, as a group, in patients with a Fontan circulation,
exercise capacity is limited and declines with age.
This decline accelerates in the adolescent years.5–10
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CLINICAL PERSPECTIVE
What Is New?

• In young subjects with a Fontan circulation,
exercise capacity as measured by cardiopulmonary exercise testing is associated with the
health of multiple noncardiovascular end-organ
systems in which progressive decline and dysfunction is common in this population.

What Are the Clinical Implications?

• Because end-organ health is associated with
exercise performance, it is reasonable to consider that increasing exercise capacity through
measures such as training, modification of lifestyle, and nutrition enhancement may improve
end-organ health and thus improve overall wellness in individuals with Fontan circulation.
• Our study identifies elements of organ function
associated with exercise capacity that may be
useful to consider as we strive to develop a condition-specific “composite score of wellness”
formula for our patients with Fontan circulation
that may aid in characterizing clinical status and
predict future outcomes.

Nonstandard Abbreviations and Acronyms
ALC
absolute lymphocyte count
CPET
cardiopulmonary exercise testing
GGT
gamma glutamyl transferase
Peak Vo2 peak oxygen consumption

Diminished exercise capacity, as measured by peak
oxygen consumption (peak Vo2), portends prognosis and predicts both increased morbidity and risk
of hospitalization, with a nearly doubled hazard of
mortality or transplant for every 10% decline in peak
Vo2.11–14
Despite these findings, there is an impressively
wide spectrum of exercise capacity in individuals with
Fontan circulation. Attention is deservedly focused on
understanding the mechanisms underlying what limits
exercise capacity; however, few studies have investigated characteristics in patients with single ventricle
and Fontan circulation who perform at normal or supranormal exercise capacity.15,16 Furthermore, there
are few data on any associations between end-organ
function and exercise capacity. Exploration of the complex interplay between end-organ functionality and
exercise capacity may provide insight into improved
understanding of the pathophysiology of the Fontan
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circulation and perhaps offer clues into ways to best
preserve organ function, overall health, and wellness.
In this study, we look to identify clinical characteristics
and end-organ parameters associated with higher exercise performance in patients with Fontan circulation.

METHODS
The authors declare that all supporting data are available within the article.
We performed a single-center retrospective analysis of subjects with a Fontan circulation evaluated at
the Children’s Hospital of Philadelphia’s Single Ventricle
Survivorship Program, between the years 2011 and
2018. Permission for data collection and analysis is
included under Institutional Review Board approval
for the Children’s Hospital of Philadelphia’s Cardiac
Center Single Ventricle—Fontan Registry (CHOP IRB
12-009791). The requirement for subjects to provide
informed consent was waived. This clinic, now known
as the Fontan Rehabilitation, Wellness, Activity and
Resilience Development program, was created to
provide multidisciplinary evaluation and surveillance
services at regular intervals to patients with a Fontan
circulation, as proposed in a consensus statement.4 All
study subjects were ambulatory and outpatient at the
time of evaluation.
Subjects were included in the study if, at their
most recent visit, they completed cardiopulmonary
exercise testing (CPET) and underwent a comprehensive end-organ surveillance evaluation, an evaluation that is intended to reflect measurable areas of
potential vulnerability in patients with a Fontan circulation. Patient cardiac anatomy, medical and surgical
history, medications, vital signs and anthropometric measures, blood laboratory data, abdominal ultrasound, and CPET peak Vo2 data were collected
cross-sectionally at their most recent Single Ventricle
Survivorship Program visit. Estimated glomerular filtration rate (eGFR) was calculated for subjects using
the updated bedside Schwartz formula.17 CPET
was performed according to standard protocols.6
Subjects who underwent ramp cycle protocols were
asked to exercise to maximal volition (respiratory exchange ratio >1.10) using an electronically braked
cycle ergometer. The protocol consists of 3 minutes
of pedaling in an unloaded state followed by a ramp
increase in work rate (W) to maximal exercise. The
steepness of the ramp protocol was determined by
subject weight in kilograms and designed to achieve
predicted peak work rate in 10 to 12 minutes of cycling time. Subjects who did not meet the height
requirements for cycle ergometry (height >130 cm)
were exercised using a graded treadmill protocol.
This consisted of 3 minutes of walking followed by
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incremental increases in speed and grade every 1
minute until maximal exercise is reached. Metabolic
and ventilatory data, including minute oxygen consumption, were obtained throughout the exercise
study and for the first 2 minutes of recovery on a
breath-by-breath basis using a metabolic cart
(SensorMedics V29, Yorba Linda, CA). For subjects
who underwent ramp cycle testing, peak Vo2 data
were converted to percent predicted peak Vo2 based
on age and sex.18 High performers were defined as
individuals performing ≥80% predicted peak Vo2.

Statistical Analysis
Student t test for continuous variables and χ2 test for
categorical variables was used to compare clinical
characteristics and end-organ parameters between
high performers and those performing below 80%
predicted peak Vo2. Pearson correlation coefficient
was used to measure the correlation between age
and peak Vo2. Univariate linear regression model was
used to study the association between independent clinical characteristic variables and the outcome
peak Vo2. The magnitude of the association between
clinical characteristics and exercise capacity was
calculated and reported as an effect size of absolute
change in peak Vo2. Among the continuous variables,
several were re-scaled to allow for interpretation of a
clinically meaningful effect size: absolute lymphocyte
count (ALC) and platelet count values were divided
by 100, and brain natriuretic peptide, 25-OH vitamin
D, intact parathyroid hormone, eGFR, and gammaglutamyl transferase (GGT) values were divided by
10. For clinical characteristics expected to have a
significant correlation with age (extracardiac conduit
Fontan, liver span size), a linear regression model
with age as an additional independent variable was
performed. To assess the effect of liver span size
when accounting for the effect of body mass, additional linear regression models with weight or body
mass index (BMI) percentile as additional independent variables were performed. We also conducted
a multivariable regression analysis to examine the
adjusted association between clinical characteristics and the outcome peak Vo2. To select variables
for the multivariable regression, we examined the
correlation between each pair of clinical characteristics that had P<0.1 in the univariate analysis and
calculated the variance inflation factor to quantify
multicollinearity among variables. Among highly
correlated variables, we chose variables based on
their clinical importance and the primary research
interest of this study. Multivariable regression models including and excluding age as a variable were
performed. The final model included vitamin D sufficiency, platelet count, ALC, hemoglobin, sex, and
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obesity. Age was not included in the final model because of collinearity with other variables, with the
study objective to evaluate the association between
exercise performance and end-organ function variables that may prove to be modifiable. In the univariate analysis, we used Bonferroni approach to adjust
for multiple comparisons. A P<0.0025 was considered as statistical significance at the nominal level
of 0.05. All statistical analysis was performed in R
version 3.6.0.

RESULTS
Overall Cohort Characteristics and
Association With End-Organ Parameters
A total of 421 subjects were seen in the Fontan
Rehabilitation, Wellness, and Resilience Development
clinic during the study period. Of 334 subjects who
attempted exercise testing, 265 achieved maximal
exercise testing and met inclusion criteria for analysis. Of these, 163 subjects completed exercise testing per the ramp cycle protocol and 102 subjects
completed graded treadmill protocol exercise testing. Table 1 summarizes key demographic and clinical characteristics of the 265 subjects in the study
cohort. Subjects range in age from 5.5 to 48 years,
with a median of 12.8 years; 37% are female, and
16% are overweight or obese. Most of the group
comprises individuals with a dominant right ventricular morphology of their single ventricle, 32 (12%)
have heterotaxy syndrome, and 81% received a fenestration at the time of their Fontan surgery. Three
subjects died subsequent to evaluation. Proteinlosing enteropathy (active or controlled under treatment) is present in 22 (8%) and plastic bronchitis in
6 (2%) subjects. Brain natriuretic peptide levels are
within normal range of <100 pg/mL in the vast majority; however, it is >250 pg/mL in 2 subjects (1%).
Hypoalbuminemia defined as albumin <3.5 g/dL is
present in 17 subjects (6%). GGT levels are abnormally above the upper level of normal for age and
sex, as per the Children’s Hospital of Philadelphia’s
core laboratory reference ranges, in 223 subjects
(94%). As for other markers of end-organ function,
74 subjects (28%) have calculated eGFR <90 mL/min
per 1.73 m2, 84 subjects (32%) have platelet counts
below the lower level of normal for age and sex, and
48 subjects (19%) have ALCs less than the lower level
of normal for age and sex. Two-hundred-one subjects (81%) demonstrate vitamin D sufficiency (defined as 25-OH vitamin D >20 ng/mL).
The distribution of absolute peak Vo2 values by
age for the entire study cohort is displayed in the
Figure. The median peak Vo2 is 32.6 mL/kg per
minute. There is a significant negative correlation
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Table 1. Key Demographic and Clinical Characteristics of
the Study Cohort
All Subjects (N=265)
Age at FORWARD visit, y

12.8 (9.5–16.4)

Female

97 (37%)

Right heart morphology of single ventricle

164 (62%)

Hypoplastic left heart syndrome
Extra cardiac conduit Fontan
Age at Fontan palliation, y
Fenestrated Fontan

125 (47%)
148 (56%)
2.6 (2.0–3.4)
197 (81%)

Number of cardiovascular medications

2 (1–3)

Protein losing enteropathy

22 (8%)

Plastic bronchitis

6 (2%)

Pulse oximetry (%)

94 (91–95)

Body mass index percentile (%)*
†

Overweight/obese

Brain natriuretic peptide, pg/mL
International normalized ratio
Gamma glutamyl transferase, U/L
Albumin, g/dL
Liver span size, cm‡

44 (17–72)
38 (16%)
19 (10–34)
1.20 (1.15–1.26)
50 (36–75)
4.6 (4.3–4.9)
13.9 (12.6–15.4)

eGFR, mL/min per 1.73 m2§

105 (89–118)

Platelet count, K/μL

223 (173–275)

Hemoglobin, g/dL
Absolute lymphocyte count, K/μL
Calcium, mg/dL
25-OH vitamin D, ng/mL

14.9 (14.1–16)
1440 (1111–1825)
9.6 (9.3–9.9)
30 (22–38)

Vitamin D sufficiency||

201 (81%)

Intact parathyroid hormone, pg/mL

49 (33–76)

Categorical variables labeled with number (%). Continuous variables
labeled with median and interquartile range (25%–75%). eGFR indicates
estimated glomerular filtration rate; and FORWARD indicates Fontan
Rehabilitation, Wellness, and Resilience Development.
*Body mass index percentile excludes subjects >20 years of age.
†
Overweight/obese defined as body mass index percentile ≥85th
percentile for age and sex.
‡
Liver span size as measured on abdominal ultrasound.
§
Calculated by bedside Schwartz formula: 0.413×height (cm)/creatinine
(mg/dL).
||
Defined as 25-OH vitamin D ≥20 ng/mL.

between peak Vo2 and age, with a Pearson correlation of −0.49, P<0.001.

Characteristics of High Performers and
Association With End-Organ Parameters
When stratifying the cohort between individuals performing above (high performer) and below 80 percent
predicted peak Vo2, 34% of subjects perform above
80%. Higher performers exhibit a distinct profile as
they are significantly younger, more likely female, and
have end-organ parameters that demonstrate higher
eGFR, vitamin D sufficiency, and lower GGT. Higher
performers trend toward lower hemoglobin, higher
platelet count, and higher ALCs (Table 2).

Single variable regression of the association of
changes in clinical characteristics and peak Vo2 listed
in order of greatest positive to greatest negative effect
is shown in Table 3. Significant greatest positive effects
include vitamin D sufficiency, extracardiac conduit type
of Fontan palliation, platelet count, ALC, and eGFR.
Absolute vitamin D and calcium levels have a nearly
significant positive effect on peak Vo2. Significant
greatest negative effects include status as overweight
or obese and number of cardiovascular medications.
Hemoglobin and GGT values trend toward negative
association with peak Vo2.
Liver span size as measured by abdominal ultrasound demonstrates significant negative association
with peak Vo2 (−0.82, P<0.001). Because liver span
size may be confounded by age and body mass, additional linear regressions were performed adjusting
for age, BMI percentile, or weight. With such indexing
to age and body size, no significant effect was seen
between liver span and peak Vo2. An additional independent variable expected to have a significant correlation with age is the extracardiac conduit type of
Fontan, as this type of Fontan surgery was performed
with greater frequency in our younger population. A
multivariable linear regression model with age as an
additional independent variable eliminated the statistically significant positive association with peak Vo2
related to undergoing extracardiac conduit type of
Fontan. Of note, age at Fontan surgery, underlying
morphology of the single ventricle, protein-losing enteropathy or plastic bronchitis, and brain natriuretic
peptide levels do not demonstrate a significant effect
on peak Vo2.

Multivariate Analysis of Parameters
Associated With Exercise Performance
Results of multivariate linear regressions are demonstrated in Table 4. Including age in the model yields
a very strong negative association between age and
exercise performance. Obesity is also significantly
negatively associated. Multivariate linear regression
excluding age shows vitamin D sufficiency and ALCs
have a significant positive relationship with peak Vo2,
and hemoglobin level and status as overweight or
obese have a significant negative relationship with
peak Vo2. Platelet count has a nearly significant positive relationship with peak Vo2. Inclusion of GGT and
eGFR in the model did not demonstrate statistical
significance.

DISCUSSION
In this study we explore the relationship between the
status of cardiovascular wellness as gauged by CPETmeasured peak Vo2 and clinical characteristics of
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Figure 1. Distribution of peak oxygen consumption (peak Vo2) and age.
This figure demonstrates the cross-sectional distribution of all 265 study subjects’ peak Vo2 performance
and age in years. The figure demonstrates a significant downward slope in exercise performance with age,
with a significant negative correlation between peak Vo2 and age (Pearson correlation −0.49, P<0.001).

end-organ function as measured by laboratory values,
in a large cohort of outpatients with a Fontan circulation. Younger age, vitamin D sufficiency, absence of
overweight or obese status, lower hemoglobin, higher
ALC, and a healthier hepatic profile are associated with
higher exercise performance on CPET. Anatomic morphology of the single ventricle, timing of Fontan palliation, and type of Fontan are not significantly associated
with exercise performance.
In our study cohort, >30% of the subjects undergoing ramp cycle CPET performed at a peak Vo2 >80%
predicted for age. Although physiologically challenged
with the absence of a subpulmonary ventricle, individuals with Fontan circulation exhibit wide variability in their exercise capacities with reassurance that
a significant subset appear to perform very well. As
a comparison, in studies assessing “Super-Fontans”
or “High-Capacity Fontans,” defined as individuals
achieving >80% of predicted peak Vo2, high-achieving
performance was seen in 11% and 19% of subjects,
respectively.15,16 Differences in patient phenotype, particularly the older ages of the subjects in each of these
studies, may explain their lower prevalence of higher
exercise performance. Clearly there is a subset of individuals with Fontan circulation who perform at a high
level, but what defines and characterizes this group?
Can a deeper analysis of overall health status offer insights into their uniqueness?
We found a significant negative correlation between
peak Vo2 and age, with a steep decline particularly

notable in adolescence, supporting several prior studies.5–10 When including age in our multivariable regression analysis model, the strength of the association
with exercise performance is dominant and only obesity is additionally of significance. This speaks to the
sobering reality that age, or simply the time elapsed
with having a Fontan circulation, may be the strongest
factor influencing exercise performance, perhaps suggesting unmitigated decline of capacity with passage
of time. Because age is nonmodifiable, we performed
an additional regression model excluding age to identify additional variables that may be related to exercise
capacity. We discover that, besides age, other variables appear to be of importance. We hypothesize a
complex interplay and possible association between
healthier end-organ systems and increased exercise
capacity. Using laboratory values to reflect hepatic,
hematologic, renal, and musculoskeletal health, we
found that healthier end-organ function in each of
these systems is associated with increased exercise
performance.
In regard to musculoskeletal health, vitamin D sufficiency demonstrates the strongest positive association with exercise performance. Vitamin D deficiency
in patients with Fontan circulation is associated with
lower-leg lean mass z-scores and sarcopenia, which
negatively influences exercise capacity.19,20 Vitamin D
stores are known to reflect musculoskeletal health and
physical activity levels in children and adolescents.21
The identified positive association between vitamin D
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Table 2. Key Demographic and Clinical Demographics in
Subjects Undergoing Cycle Ramp Protocol, With Statistical
Analysis Between Cohorts Stratified Above and Below 80%
Predicted Peak Vo2

Age at FORWARD
visit, y

Peak Vo2
≥80%
(N=56)

Peak Vo2
<80%
(N=107)

P Value

12.3
(10.3–13.7)

16.0 (14.2–18.8)

<0.001*

Female

28 (50%)

30 (28%)

0.005

Right heart morphology
of single ventricle

33 (59%)

62 (58%)

0.904

Extra cardiac conduit
Fontan

35 (63%)

Age at Fontan
palliation, y

2.7 (2.0–3.6)

Number of
cardiovascular
medications

2 (1–2)

Protein losing
enteropathy or plastic
bronchitis

4 (7%)

50 (48%)
2.1 (1.8–3.1)
2 (1.5–3)

11 (10%)

0.072
0.568
0.002†

0.510

Pulse oximetry (%)

94 (91–96)

94 (91–95)

0.487

Body mass index
percentile (%)‡

54 (16–75)

44 (16–72)

0.637

Overweight/obese

§

Brain natriuretic
peptide, pg/mL
International normalized
ratio
Gamma glutamyl
transferase, U/L
Albumin, g/dL
||

9 (17%)

16 (17%)

0.987

18 (5–26)

20 (10–38)

0.157

1.17 (1.13–1.26)

1.22 (1.16–1.26)

0.491

51 (42–65)

56 (40–90)

0.002†

4.7 (4.5–4.9)

4.7 (4.5–4.9)

0.567

13.9 (12.7–15.1)

15.2 (14.2–16.3)

0.147

eGFR, mL/min per
1.73 m2¶

111 (97–121)

98 (85–111)

0.0006†

Platelet count, K/μL

227 (187–260)

182 (150–251)

0.014

Liver span size, cm

Hemoglobin, g/dL

14.7 (14.2–15.5) 15.4 (14.4–16.4)

0.012

Absolute lymphocyte
count, K/μL

1560
(1266–1883)

1220
(965–1625)

0.151

Vitamin D sufficiency#

49 (92%)

70 (69%)

0.001†

Calcium, mg/dL

9.6 (9.4–9.8)

9.6 (9.3–9.9)

0.590

25-OH vitamin D, ng/
mL

31 (23–40)

25 (18–36)

0.134

Intact parathyroid
hormone, pg/mL

46 (34–74)

52 (37–83)

0.190

Categorical variables labeled with number (%). Continuous variables
labeled with median (25%–75%). Univariate analysis performed with Student
t test for continuous variables and χ2 analysis for categorical variables.
eGFR indicates estimated glomerular filtration rate; FORWARD, Fontan
Rehabilitation, Wellness, and Resilience Development; and Vo2, oxygen
consumption.
*Signifies P<0.00004 (0.001/24).
†
Signifies P<0.0021 (0.05/24).
‡
Body mass index percentile excludes subjects ≥20 years of age.
§
Overweight/obese defined as body mass index percentile ≥85th
percentile for age and sex.
||
Liver span size as measured on abdominal ultrasound.
¶
Calculated by bedside Schwartz formula: 0.413×height (cm)/creatinine
(mg/dL).
#
Defined as 25-OH vitamin D ≥20 ng/mL.

Table 3. Single Variable Regression of Impact of Changes
in Clinical Characteristics on Peak Vo2
Effect Size*

P Value

Vitamin D sufficiency

4.48

<0.001†

Extracardiac conduit Fontan

3.14

0.001‡

Platelet count, K/μL§

2.32

<0.001†

Calcium, mg/dL

2.05

0.029

25-OH vitamin D, ng/mL||

0.97

0.005

eGFR, mL/min per 1.73 m2||,¶

0.63

0.002‡

Absolute lymphocyte count, K/μL§

0.28

<0.001†

Pulse oximetry, %
Body mass index percentile, %#

0.26

0.030

−0.05

0.004

Brain natriuretic peptide, pg/mL||

−0.16

0.135

Gamma-glutamyl transferase, U/L||

−0.23

0.037

Intact parathyroid hormone, pg/mL||

−0.24

0.059

Hemoglobin, g/dL

−0.84

0.009

Number of cardiovascular medications

−1.45

<0.001†

Female

−1.81

0.072

Protein-losing enteropathy or plastic
bronchitis

−1.85

0.240

Overweight/obese#

−5.16

<0.001**

eGFR indicates estimated glomerular filtration rate; and Vo2, oxygen
consumption.
*Absolute change in peak Vo2 for an increase of 1 for continuous variables
or for a value of 1 for dichotomous variables.
†
Signifies P<0.0005 (0.01/20).
‡
Signifies P<0.0025 (0.05/20).
§
Re-scaled by dividing variable by 100 for clinically meaningful effect size.
||
Re-scaled by dividing variable by 10 for clinically meaningful effect size.
¶
Calculated by bedside Schwartz formula: 0.413×height (cm)/creatinine
(mg/dL).
#
Excludes analysis for subjects ≥20 years of age or with protein-losing
enteropathy.
**Signifies P<0.0025 (0.05/20).

sufficiency and peak Vo2 in individuals with a Fontan
circulation suggests that maintenance of regular physical activity may beget improved maximal exercise
capacity. Vitamin D sufficiency might be protective
against sarcopenia in patients with a Fontan circulation
and vitamin D supplementation and/or maintenance of
frequent exercise activity at a younger age may have a
long-lasting beneficial role.
We found overweight or obese subjects to have
a significant decreased peak Vo2 compared with
subjects with BMI less than the 85th percentile.
Higher BMI z-score is associated with decreased
exercise performance in children and adolescents
with Fontan circulation.22 Patients with Fontan circulation, like many children with complex congenital
heart disease, are likely to have their activity levels
restricted by their cardiologist, associated with decreased weekly exercise activity levels and increased
BMI.23 This finding further supports the implication
that, specifically for the child with Fontan circulation,
regular physical activity may beget improved maximal exercise capacity.
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Table 4. Multivariate Linear Regressions of Association Between Clinical Characteristics and Peak Vo2 , With Age Included
and Excluded in the Model
Age Included

Age Excluded

Effect Size*

P Value

Effect Size*

P Value

Vitamin D sufficiency

1.47

0.142

3.00

0.020†

Platelet count K/μL‡

0.20

0.844

1.24

0.055

Absolute lymphocyte count, K/μL ‡

1.24

0.216

0.23

0.005§

Hemoglobin, g/dL

−0.70

0.485

−0.77

0.014†

Female

−1.89

0.061

−1.73

0.076

Overweight/obese

−3.12

0.002§

−3.91

0.003§

Age, y

−6.91

<0.001||

…

…

Vo2 indicates oxygen consumption.
*Absolute change in peak Vo2 for an increase of 1 for continuous variables or for a value of 1 for dichotomous variables.
†
Signifies P<0.05.
‡
Re-scaled by dividing variable by 100 for clinically meaningful effect size.
§
Signifies P<0.01.
||
Signifies P<0.001.

We found a higher lymphocyte count associated
with better exercise capacity. Lymphopenia is seen
in patients with Fontan circulation24 and is presumably related to lymphatic congestion and low levels of
chronic enteric lymph loss. Lower lymphocyte levels
may reflect a greater degree of lymphatic and venous
congestion and may be a surrogate for relatively suboptimal hemodynamics, manifested as limitations in
exercise capacity.
Subjects with a higher hemoglobin level have an
associated significant decreased peak Vo2. Higher hemoglobin levels among subjects within our overall cohort, for which there is an elevated median hemoglobin
of 14.9 mg/dL, likely reflect a reactive polycythemia to
mild cyanosis. Reactive polycythemia may indicate
sustained, relatively lower oxyhemoglobin saturations
and, despite an attempt at physiological compensation, may reflect limitations to oxygen-carrying capacity
that influence peak exercise capacity in these individuals. In support of this theory, resting oxyhemoglobin
saturations trend toward a positive relationship with
peak Vo2 in our univariate analysis. In contrast, previous research has demonstrated a positive correlation
between peak Vo2 and hemoglobin in a cohort of 115
6-to-20 year-old subjects with a Fontan circulation.10
More detailed study incorporating the fundamental
causes of lower oxygen saturation such as fenestration
patency versus venous collaterals or intrapulmonary
shunting, as well as improved understandings of iron
absorption and individual capacity for red blood cell
production, will provide a clearer picture on the value
of hemoglobin level as a parameter of wellness or unwellness in the Fontan circulation.
As for hepatic end-organ health, we found that subjects with higher platelet counts perform at higher associated peak Vo2 on univariate analysis and have a
trend toward higher associated peak Vo2 on multivariate

analysis. Subjects with lower GGT values trend toward
higher associated peak Vo2. Fontan-associated liver
disease, attributed to elevated central venous pressures and increased hepatic congestion, may be characterized serologically by elevated GGT and decreased
platelet counts.25–27 Our data suggest that subjects
with higher exercise performance may exhibit more
favorable hemodynamic conditions, perhaps a lower
central venous pressure and thus decreased hepatic
congestion, than their lower-performing peers.
Though not significant in multivariate regression,
univariate analysis demonstrates an association between higher glomerular filtration rate and exercise capacity as measured by peak Vo2. Renal dysfunction in
the Fontan circulation is attributed to decreased kidney
perfusion as a result of low cardiac output inherent to
the Fontan circulation, in addition to multiple lifetime
exposures to renal toxicities (prolonged cyanosis, cardiopulmonary bypass runs, nephrotoxic medications,
and intravenous contrast).4 In patients with Fontan circulation, low stroke volume index at maximal exercise
is proposed as the most important factor limiting exercise capacity.28 Higher glomerular filtration rate likely
reflects a better hemodynamic status in the individual.
Though the bedside Schwartz formula is a good surrogate measure of glomerular filtration rate in a study
population such as ours mostly comprising individuals
below the age of 18 years, the lack of statistical significance between peak Vo2 and eGFR on multivariate
analysis may be because creatinine, used in the calculation, is known to be a late marker of renal dysfunction in individuals with a Fontan circulation.29 Cystatin
C levels may be more sensitive in childhood and thus
is the preferred tool to use as surveillance for renal
performance.4
Are these findings fixed or is there a possibility for
modification? It is plausible to presume that enhancing
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exercise capacity in individuals with a Fontan circulation at younger ages might also influence and modify
end-organ functionality. Investigators have demonstrated that high-intensity resistance training and inspiratory muscle training can have significant effects
on cardiac output and exercise capacity,30,31 whereas
aerobic exercise training has not demonstrated similar
lasting effects in this patient population.32,33 Weekly
sports participation and exercise more than 4 days
per week has been demonstrated to be associated
with increased exercise capacity on exercise testing.16,34 Medication treatment with phosphodiesterase
type 5 inhibition has recently been demonstrated to
improve submaximal measures of exercise performance.35 These types of interventions may augment
exercise capacity, which could reciprocally influence
end-organ functionality and, based on our findings
of associations, is deserving of further investigation.
Alternatively, it is possible that these findings of organ
dysfunction are fixed, and that there is an underlying heterogeneity in organ functional capacity in individuals who have undergone the Fontan palliation.
Heterogeneity in the Fontan population may be related
to factors such an inherent “resilience” or the underlying genetics and prenatal environment, among others, variables that might limit or benefit an individual’s
potential for exercise capacity as well as end-organ
function.
An important limitation of our study data is that
peak Vo2 was measured via graded treadmill protocol
in about 40% and ramp cycle protocol in about 60%
of subjects. Ideally, all subjects would have exercise
tests in accordance with one protocol; however, the
relatively young age span of our cohort was prohibitive.
To address this, we performed a subanalysis of only
ramp cycle protocol subjects for analysis of the high
performers (>80% predicted peak Vo2 versus <80%,
Table 2) but analyzed the influence of organ functionality on exercise performance using absolute peak Vo2
for the entire cohort (Tables 3 and 4), with similar trends
in associations for the subgroup and overall noted.
An additional limitation is the cross-sectional nature
of the data derived from a single center. Longitudinal
data would more accurately describe the trajectory of
exercise performance as individual patients transition
from childhood through adolescence and into adulthood. In addition, the selection of peak Vo2 as the
primary outcome is a limitation in the study, as this
variable does not reflect the most common type of
day-to-day activity undertaken by subjects. Additional
exercise parameters may be useful to study, including
Vo2 at anaerobic threshold and work rate at peak exercise. Nevertheless, we selected peak Vo2 because
it is a measurement frequently used in the literature
and is commonly associated with morbidity and mortality in patients with a Fontan circulation. Additional
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parameters that we did not assess but would be of
value to analyze in future study include self-reported
activity level and sports participation, as well as imaging measures of ventricular and atrioventricular valve
performance. Lastly, there is selection bias, because
the 265 study subjects are derived from a larger cohort
of patients seen in the Fontan Rehabilitation, Wellness,
and Resilience Development clinic during this time period. Of the 156 subjects who did not undergo interpretable CPET studies, a subset was physically and/
or cognitively unable to complete CPET and may represent a patient population with a greater degree of
cardiovascular dysfunction and end-organ morbidity.
Others who were excluded were too young to participate in CPET, which may provide for further age-related bias. Our findings thus apply towards a selected,
healthier population, but do likely reflect a majority of
relatively young Fontan circulation individuals within
the community who appear well, are outpatients, and
visit their healthcare providers 1 to 2 times per year for
surveillance.
Our study findings lay the groundwork for further
exploration. Future prospective longitudinal assessments with larger cohorts of patients with Fontan
circulation could further assess the efficacy of interventions such as cardiopulmonary rehabilitation,
lower-extremity leg muscle mass strengthening, and
medication management as modalities for improving cardiopulmonary exercise testing performance.
Importantly, we anticipate our findings will aid in developing a condition-specific “composite score of
wellness” for patients with a Fontan circulation. The
parameters we evaluated reflect measurable areas of
potential vulnerability in patients with a Fontan circulation. We identify clinical characteristics and important
elements of end-organ function that are strongly associated with exercise capacity, as well as elements
not associated. We do not know or expect that any
specific improvement in one or a group of variables
will lead to an increase or decrease in exercise performance; rather, we are demonstrating the magnitude
of association of a specific end-organ variable with a
measure of cardiovascular wellness, that of exercise.
In understanding the strength of the association with
exercise performance, we have laid the foundations
for identifying variables to include in development of
such a Fontan circulation wellness score. Age, overweight/obesity status, vitamin D sufficiency, platelet
count, lymphocyte count, hemoglobin, and eGFR are
candidate elements to include in the development of
such a wellness prediction model, while ventricular
morphology is not. Future endeavors would be to develop a model using these elements, among others,
and to apply the model prospectively to determine
utility to predict outcome measures (ie, transplant-free
survival and quality of life).
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CONCLUSIONS
In a cohort of 265 subjects with a Fontan circulation, younger age, vitamin D sufficiency, absence
of overweight or obese status, lower hemoglobin
and laboratory values reflecting higher lymphocyte
counts and a healthier hepatic profile are associated with higher performance on cardiopulmonary
exercise testing. Anatomic morphology of the single ventricle, timing of Fontan palliation, and type
of Fontan surgery do not have a significant association with peak Vo2. Our study identifies important elements of organ function associated with
exercise capacity that may be useful to consider as
we attempt to develop a condition-specific “composite score of wellness” formula for our patients
with Fontan circulation, which could then be tested
to predict future outcomes. For healthcare providers caring for patients with a Fontan circulation, our
data suggest that exercise capacity is associated
with the health of multiple end-organ systems in
which natural progressive decline and dysfunction
is common. Whether exercise training at younger
ages or other initiatives can modify organ dysfunction is worthy of future exploration.
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